rs143474305

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 3P and 18B. PM1PP3BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000202.8(IDS):​c.727C>T​(p.Pro243Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,209,588 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 66 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P243P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.00018 ( 0 hom. 60 hem. )

Consequence

IDS
NM_000202.8 missense

Scores

9
5
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 9.56

Publications

2 publications found
Variant links:
Genes affected
IDS (HGNC:5389): (iduronate 2-sulfatase) This gene encodes a member of the sulfatase family of proteins. The encoded preproprotein is proteolytically processed to generate two polypeptide chains. This enzyme is involved in the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this gene are associated with the X-linked lysosomal storage disease mucopolysaccharidosis type II, also known as Hunter syndrome. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
IDS Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 2
    Inheritance: XL, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, PanelApp Australia, Myriad Women’s Health
  • mucopolysaccharidosis type 2, attenuated form
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • mucopolysaccharidosis type 2, severe form
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_000202.8
PP3
Multiple lines of computational evidence support a deleterious effect 9: BayesDel_addAF, BayesDel_noAF, Cadd, Dann, M_CAP, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when AlphaMissense, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.19139543).
BP6
Variant X-149496498-G-A is Benign according to our data. Variant chrX-149496498-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 457355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000214 (24/111945) while in subpopulation NFE AF = 0.00032 (17/53187). AF 95% confidence interval is 0.000203. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 6 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IDSNM_000202.8 linkc.727C>T p.Pro243Ser missense_variant Exon 6 of 9 ENST00000340855.11 NP_000193.1
IDSNM_001166550.4 linkc.457C>T p.Pro153Ser missense_variant Exon 6 of 9 NP_001160022.1
IDSNM_006123.5 linkc.727C>T p.Pro243Ser missense_variant Exon 6 of 8 NP_006114.1
IDSNR_104128.2 linkn.896C>T non_coding_transcript_exon_variant Exon 6 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IDSENST00000340855.11 linkc.727C>T p.Pro243Ser missense_variant Exon 6 of 9 1 NM_000202.8 ENSP00000339801.6
ENSG00000241489ENST00000651111.1 linkc.94C>T p.Pro32Ser missense_variant Exon 11 of 14 ENSP00000498395.1

Frequencies

GnomAD3 genomes
AF:
0.000214
AC:
24
AN:
111945
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.0102
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000320
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000137
AC:
25
AN:
181995
AF XY:
0.0000891
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000298
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000179
AC:
196
AN:
1097643
Hom.:
0
Cov.:
30
AF XY:
0.000165
AC XY:
60
AN XY:
363113
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26390
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.0000370
AC:
2
AN:
54123
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40527
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3893
European-Non Finnish (NFE)
AF:
0.000225
AC:
189
AN:
841862
Other (OTH)
AF:
0.0000869
AC:
4
AN:
46053
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000214
AC:
24
AN:
111945
Hom.:
0
Cov.:
23
AF XY:
0.000176
AC XY:
6
AN XY:
34115
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30736
American (AMR)
AF:
0.00
AC:
0
AN:
10590
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3577
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2709
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6078
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.000320
AC:
17
AN:
53187
Other (OTH)
AF:
0.00
AC:
0
AN:
1493
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000378
Hom.:
2
Bravo
AF:
0.000246
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000988
AC:
12
EpiCase
AF:
0.000218
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IDS: BS2 -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Jul 09, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.727C>T (p.P243S) alteration is located in exon 6 (coding exon 6) of the IDS gene. This alteration results from a C to T substitution at nucleotide position 727, causing the proline (P) at amino acid position 243 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

IDS-related disorder Benign:1
Jun 17, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Mucopolysaccharidosis, MPS-II Benign:1
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Pathogenic
0.35
D
BayesDel_noAF
Pathogenic
0.63
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.94
D;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D;D;D
M_CAP
Pathogenic
0.90
D
MetaRNN
Benign
0.19
T;T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.3
M;M;.
PhyloP100
9.6
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-6.6
D;D;.
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0070
D;D;.
Sift4G
Uncertain
0.017
D;D;D
Polyphen
0.99
D;D;.
Vest4
0.66
MVP
0.97
MPC
0.79
ClinPred
0.34
T
GERP RS
5.8
Varity_R
0.89
gMVP
0.85
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143474305; hg19: chrX-148578029; COSMIC: COSV61711663; COSMIC: COSV61711663; API